To evaluate efficacy of Bacillus calmette-guerin (Bcg) in reducing the incidence & severity of Covid-19 in the high-risk population (Bric)- A Phase III, multicentric, quadruple blind randomized controlled trial
Implementing Organization
All India Institute of Medical Sciences
Principal Investigator
Prof. S. Sinha All India Institute of Medical Sciences Delhi